Introduction
Case report
• Opportunistic infections are a recognised complication of severe hypercortisolism.
• We report a case of Pneumocystis Jiroveci Pneumonia (PCP for formerly named Pneumocystis carinii pneumonia) in patient with ectopic Cushing's syndrome caused by a metastatic large cell neuroendocrine carcinoma of the lung.
• A 61-year old male attended the Acute Medical Unit for investigation and treatment of severe and recurrent hypokalaemia (K<2.5 mmol/l). Other cushingoid features included hypertension, easy bruising and central fat distribution.
• His random cortisol at presentation was 1404 nmol/L, 24-h urine free cortisol of 6363 nmol/24h (upper limit of normal 270) and plasma ACTH was 250 ng/L(normal <50) confirming a diagnosis of ACTH dependent Cushing's syndrome. A repeat 9 am cortisol was >2000 nmol/l
• Corticotrophin-Releasing Hormone (CRH) test (Table 1 ) was suggestive of ectopic ACTH secretion (ACTH increment <50%).
• CT whole body demonstrated a left upper lobe lung nodule with multiple liver metastases.
• Liver biopsy and immune-histochemistry confirmed the diagnosis of a large cell neuroendocrine carcinoma, metastatic from the lung.
Management and complications
• Patient treated initially with Spironolactone 50mg od . Metyrapone 250mg tds started after confirmation of diagnosis of ectopic ACTH Cushing's disease for management of severe hypokalaemia and hypercortisolaemia. Metyrapone dose gradually increased to 750mg tds and ketoconazole was added to the treatment. There was improvement in serum cortisol (655nmol/l) and potassium (3.5 mmol/l) levels.
• Decision from oncology MDT was for palliative chemotherapy.
• One week after initiation of treatment with metyrapone, patient developed cough, fever, shortness of breath and he was desaturating on air (Sa02:88% on Air).
• He was treated with intravenous antibiotics for hospital acquired pneumonia and oxygen. A CXR ( Figure 1 ) and a CTPA (Figure 2 ) showed bilateral upper lobe dense consolidation. Patient started on empirical treatment for PCP with co-trimoxazole (oral) and a broncho-alveolar lavage (BAL) confirmed the diagnosis.
• Treatment for PCP continued for 21 days, patient's condition improved and discharged from the hospital with oxygen. Decision from oncology team after discussion with patient was not to provide chemotherapy due to overall deterioration. Patient referred to McMillan palliative team for symptom control . Table 1. CRH test results  Table 2 . Gut hormone measurement Figure 1 . CXR Figure 2 . CTPA
Discussion
• Similar to our case, PCP has been diagnosed after initiation of cortisol-lowering therapy in the majority of the reported cases in patients with Cushing's syndrome 1 .
• This suggests that immune reconstitution is an important component or even a prerequisite for development of clinically overt PCP in this population. There seems to be a relationship between the degree of hypercortisolism and the susceptibility to opportunistic infections 2 .
• Our case highlights the fact that patients with severe hypercortisolaemia, more commonly seen in ectopic ACTH syndrome, may be at particular risk of PCP infection following treatment with cortisol-lowering agents.
• Prophylaxis against PCP should be considered before starting cortisol-lowering therapy in order to minimise the risk of PCP 1, 3 .
